Rat Model Market Worth USD 602.3 Million by 2020

Aug 25, 2015, 07:30 ET from MarketsandMarkets

PUNE, India, August 25, 2015 /PRNewswire/ --

According to a new market research report "Rat Model Market by Type (Outbred, Knockout, Conditioned], Technology (Microinjection, Embryonic Stem Cells), Application (Toxicology, Oncology, CNS), Service (Breeding, Cryopreservation, Quarantine) & Care Products (Cages, Bedding, Feed) - Forecasts to 2020", published by MarketsandMarkets, this report studies the global Rat Model Market over the forecast period of 2015 to 2020. This market is estimated at USD 358.5 Million in 2014 and is expected to reach USD 602.3 Million by 2020, growing at a CAGR of 9.4% from 2015 to 2020.

Browse 119 market data Tables and 19 Figures spread through 299 Pages and in-depth TOC on "Rat Model Market"

Early buyers will receive 10% customization on this report. 

The global Rat Model Market is categorized into four broad segments, namely, by type, by technology, by application, and by service. The rat model market, by type, comprises inbred, outbred, congenic/hybrid, surgically modified, knockout, and immunodeficient rats. The market for technology is segmented into microinjection, embryonic stem cell technique, nuclear transferase, and others. By application, the Rat Model Market is segmented into toxicology, diabetes, CNS, oncology, immunology, inflammation, and others. The market for rat model services is segmented into breeding, cryopreservation, quarantine, rederivation, genetic testing, model in-licensing, and other services (surgical and line rescue). The report also includes the rat care products market, which includes cages, feed, bedding, and others.

Ask for PDF Brochure: http://www.marketsandmarkets.com/pdfdownload.asp?id=76036494

The major factors propelling the growth of the Rat Model Market include the introduction of transgenic rat models, growing biomedical and translational research, ongoing preclinical activities in life sciences, growing field of personalized medicine, growing biosimilars market, and increasing government investments and funds that have stimulated the usage of advanced rat models in the biotechnology and pharmaceutical industries. Furthermore, research into cancer and neurology has increased the application areas of rat models

The U.S. accounts for the largest share of the rat model market. This large share can be attributed to the growing epidemiology of diseases and simultaneous investments in the development of rat models, revised funding plans by the NIH to enhance the reproducibility of results in preclinical tests, increasing preclinical services for biosimilars, growing biomedical research, and increasing preclinical activities by CROs and pharmaceutical industries.

However, China is expected to witness highest growth in the rat model market, followed by Germany, during the forecast period. A number of factors such as international alliances for R&D activities, increasing investments in government and private sectors in the life sciences sector, and less stringent laws (as compared to developed markets) are driving the growth of the Chinese Rat Model Market.

Major players in the Rat Model Market include Charles River Laboratories (U.S.), Taconic Biosciences, Inc. (U.S.), Janvier Labs (France), genOway S.A. (France), Covance, Inc. (U.S.), Harlan Laboratories, Inc. (U.S.), SAGE Labs (U.S.), Transposagen Biopharmaceuticals, Inc. (U.S.), Biomedical Research Models, Inc. (U.S.), and Transviragen Inc.

Browse Related Reports: 

Mice Model Market - by Type [Inbred, Knockout, Conditioned], Technology [Microinjection, Embryonic Stem Cell], Disease [Oncology, Immunology, CNS], Service [Breeding, Cryopreservation, Quarantine] & Care Products [Cages, Bedding, Feed] - Forecasts to 2018


Pre-Clinical Imaging (In-VIVO) Market by Systems and Reagents (Optical Imaging, Micro-PET, Micro-SPECT, Micro-MRI, Micro-ultrasound, Computed Tomography, Photo Acoustic Imaging, Magnetic Particle Imaging, Multimodality Imaging) - Global Forecasts to 2019


About MarketsandMarkets  

MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model - GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Mr. Rohan
Markets and Markets 
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Email: sales@marketsandmarkets.com

Visit MarketsandMarkets Blog @ http://mnmblog.org/market-research/healthcare/biotechnology
Connect with us on LinkedIn @ http://www.linkedin.com/company/marketsandmarkets

SOURCE MarketsandMarkets